Sumida Keiichi, Molnar Miklos Z, Potukuchi Praveen K, Thomas Fridtjof, Lu Jun Ling, Matsushita Kunihiro, Yamagata Kunihiro, Kalantar-Zadeh Kamyar, Kovesdy Csaba P
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
J Am Soc Nephrol. 2017 Apr;28(4):1248-1258. doi: 10.1681/ASN.2016060656. Epub 2016 Nov 10.
Constipation is one of the most prevalent conditions in primary care settings and increases the risk of cardiovascular disease, potentially through processes mediated by altered gut microbiota. However, little is known about the association of constipation with CKD. In a nationwide cohort of 3,504,732 United States veterans with an eGFR ≥60 ml/min per 1.73 m, we examined the association of constipation status and severity (absent, mild, or moderate/severe), defined using diagnostic codes and laxative use, with incident CKD, incident ESRD, and change in eGFR in Cox models (for time-to-event analyses) and multinomial logistic regression models (for change in eGFR). Among patients, the mean (SD) age was 60.0 (14.1) years old; 93.2% of patients were men, and 24.7% were diabetic. After multivariable adjustments, compared with patients without constipation, patients with constipation had higher incidence rates of CKD (hazard ratio, 1.13; 95% confidence interval [95% CI], 1.11 to 1.14) and ESRD (hazard ratio, 1.09; 95% CI, 1.01 to 1.18) and faster eGFR decline (multinomial odds ratios for eGFR slope <-10, -10 to <-5, and -5 to <-1 versus -1 to <0 ml/min per 1.73 m per year, 1.17; 95% CI, 1.14 to 1.20; 1.07; 95% CI, 1.04 to 1.09; and 1.01; 95% CI, 1.00 to 1.03, respectively). More severe constipation associated with an incrementally higher risk for each renal outcome. In conclusion, constipation status and severity associate with higher risk of incident CKD and ESRD and with progressive eGFR decline, independent of known risk factors. Further studies should elucidate the underlying mechanisms.
便秘是基层医疗环境中最常见的病症之一,可能通过肠道微生物群改变介导的过程增加心血管疾病风险。然而,关于便秘与慢性肾脏病(CKD)之间的关联知之甚少。在一个由3504732名美国退伍军人组成的全国性队列中,估算肾小球滤过率(eGFR)≥60 ml/(min·1.73 m²),我们在Cox模型(用于事件发生时间分析)和多项逻辑回归模型(用于eGFR变化)中研究了使用诊断代码和泻药使用定义的便秘状态及严重程度(无、轻度或中度/重度)与新发CKD、新发终末期肾病(ESRD)以及eGFR变化之间的关联。在这些患者中,平均(标准差)年龄为60.0(14.1)岁;93.2%为男性,24.7%患有糖尿病。经过多变量调整后,与无便秘的患者相比,便秘患者发生CKD(风险比,1.13;95%置信区间[95%CI],1.11至1.14)和ESRD(风险比,1.09;95%CI,1.01至1.18)的发生率更高,且eGFR下降更快(eGFR斜率<-10、-10至<-5以及-5至<-1相对于-1至<0 ml/(min·1.73 m²)每年的多项比值比分别为1.17;95%CI,1.14至1.20;1.07;95%CI,1.04至1.09;以及1.01;95%CI,1.00至1.03)。更严重的便秘与每种肾脏结局风险的逐步升高相关。总之,便秘状态及严重程度与新发CKD和ESRD的较高风险以及eGFR的进行性下降相关,独立于已知风险因素。进一步的研究应阐明其潜在机制。